Members of the Board of Director
(As of November 4, 2026)
Member of the Board of Directors, Representative Director, Chairman of the Board
Takashi Yamaguchi
Career summary
| Apr. 1978 | Joined ASKA Pharmaceutical Co., Ltd. |
|---|---|
| Dec. 1987 | Member of the Board of Directors of ASKA Pharmaceutical Co., Ltd. |
| Jun. 1991 | President, Member of the Board of Directors, Representative Director of ASKA Pharmaceutical Co., Ltd. |
| Apr. 2021 | President, Member of the Board of Directors, Representative Director of the Company |
| Jun. 2021 | Member of the Board of Directors, Representative Director, Chairman of the Board of ASKA Pharmaceutical Co., Ltd. (to present) |
| Jun. 2025 | Member of the Board of Directors, Representative Director, Chairman of the Board of the Company (to present) |
-
Important Concurrent Holding of Positions
Member of the Board of Directors, Representative Director, Chairman of the Board of ASKA Pharmaceutical Co., Ltd. -
Shares held (As of June 24, 2026)
707 thousand shares -
Meeting body attended and attendance status (FY2025)
Board of Directors: 100% (15/15)
President, Member of the Board of Directors, Representative Director
Sohta Yamaguchi
Career summary
| Apr. 2008 | Joined Hitachi, Ltd. |
|---|---|
| May. 2011 | Registered as a patent attorney |
| Feb. 2016 | Joined ASKA Pharmaceutical Co., Ltd. |
| Jun. 2017 | Member of the Board of Directors, Executive Corporate Officer, in charge of Innovative Drug Discovery of ASKA Pharmaceutical Co., Ltd. |
| Jun. 2019 | Managing Member of the Board of Directors, in charge of Innovative Drug Discovery, Development, and Business Strategy of ASKA Pharmaceutical Co., Ltd. |
| Apr. 2020 | Managing Member of the Board of Directors, in charge of Innovative Drug Discovery, Development, Business Development, and Medical Affairs of ASKA Pharmaceutical Co., Ltd. |
| Apr. 2021 | Member of the Board of Directors of the Company |
| Jun. 2021 | Senior Managing Member of the Board of Directors, Representative Director of the Company President, Member of the Board of Directors, Representative Director of ASKA Pharmaceutical Co., Ltd. (to present) |
| Jun. 2025 | President, Member of the Board of Directors, Representative Director of the Company (to present) |
-
Important Concurrent Holding of Positions
President, Member of the Board of Directors, Representative Director of ASKA Pharmaceutical Co., Ltd. -
Shares held (As of June 24, 2026)
144 thousand shares -
Meeting body attended and attendance status (FY2025)
Board of Directors: 100% (15/15)
ESG Committee: 100% (3/3)
Senior Managing Member of the Board of Directors, Representative Director
Atsushi Maruo
Career summary
| Apr. 1981 | Joined The Mitsubishi Bank, Ltd. (currently MUFG Bank, Ltd.) |
|---|---|
| Apr. 2009 | Tohoku Region Manager and Sendai Branch Manager of MUFG Bank, Ltd. |
| Oct. 2010 | Corporate Officer of ASKA Pharmaceutical Co., Ltd. |
| Jun. 2011 | Member of the Board of Directors, Executive Corporate Officer of ASKA Pharmaceutical Co., Ltd. |
| Jun. 2014 | Senior Managing Member of the Board of Directors of ASKA Pharmaceutical Co., Ltd. |
| Jun. 2015 | Member of the Board of Directors of ASKA Pharma Medical Co., Ltd. Member of the Board of Directors of ASKA Animal Health Co., Ltd. |
| Jun. 2019 | Senior Managing Member of the Board of Directors, Representative Director of ASKA Pharmaceutical Co., Ltd. |
| Apr. 2021 | Member of the Board of Directors of the Company |
| Jun. 2021 | Senior Managing Member of the Board of Directors, Representative Director of the Company Member of the Board of Directors, Vice Chairman of the Board of ASKA Pharmaceutical Co., Ltd. (to present) |
| Apr. 2023 | Senior Managing Member of the Board of Directors, Representative Director, in charge of Sustainability of the Company (to present) |
-
Important Concurrent Holding of Positions
Member of the Board of Directors, Vice Chairman of the Board of ASKA Pharmaceutical Co., Ltd. -
Shares held (As of June 24, 2026)
49 thousand shares -
Meeting body attended and attendance status (FY2025)
Board of Directors: 100% (15/15)
ESG Committee: 100% (3/3)
Group Compliance Promotion Committee: 100% (2/2)
Member of the Board of Directors, Executive Corporate Officer
Maiko Mori
Career summary
| Apr. 1987 | Joined ASKA Pharmaceutical Co., Ltd. |
|---|---|
| Jun. 2011 | Director of Pharmaceutical Information Department of ASKA Pharmaceutical Co., Ltd. |
| Jul. 2017 | Director of Pharmaceutical Affairs Department of ASKA Pharmaceutical Co., Ltd. |
| Apr. 2020 | Division Director of Quality & Safety Assurance Division of ASKA Pharmaceutical Co., Ltd. |
| Jun. 2020 | Corporate Officer, Division Director of Quality & Safety Assurance Division of ASKA Pharmaceutical Co., Ltd. |
| Jun. 2022 | Member of the Board of Directors, Executive Corporate Officer, Division Director of Quality & Safety Assurance Division of ASKA Pharmaceutical Co., Ltd. (to present) Member of the Board of Directors, Executive Corporate Officer of the Company |
| Nov. 2026 | Member of the Board of Directors, Executive Corporate Officer, In charge of Human Capital Strategy of the Company (to present) |
-
Important Concurrent Holding of Positions
Member of the Board of Directors, Executive Corporate Officer, Division Director of Quality & Safety Assurance Division of ASKA Pharmaceutical Co., Ltd. -
Shares held (As of June 24, 2026)
16 thousand shares -
Meeting body attended and attendance status (FY2025)
Board of Directors: 100% (15/15)
Group Compliance Promotion Committee: 100% (2/2)
Member of the Board of Directors, Executive Corporate Officer
Fumiyoshi Yamaguchi
Career summary
| Jul. 2011 | Joined ASKA Pharmaceutical Co., Ltd. |
|---|---|
| Apr. 2019 | Corporate Officer, in charge of New Business Development and Assistant Director of Healthcare Business Unit of ASKA Pharmaceutical Co., Ltd. |
| Jun. 2020 | Corporate Officer, in charge of Special Appointments of ASKA Pharmaceutical Co., Ltd., Member of the Board of Directors of ASKA Animal Health Co., Ltd. |
| Jan. 2021 | President, Member of the Board of Directors, Representative Director of ASKA Animal Health Co., Ltd. (to present) |
| Jun. 2021 | Corporate Officer, in charge of Special Appointments of the Company |
| Jun. 2022 | Member of the Board of Directors, Executive Corporate Officer of the Company (to present) |
-
Important Concurrent Holding of Positions
President, Member of the Board of Directors, Representative Director of ASKA Animal Health Co., Ltd. -
Shares held (As of June 24, 2026)
9 thousand shares -
Meeting body attended and attendance status (FY2025)
Board of Directors: 100% (15/15)
ESG Committee: 100% (3/3)
Group Compliance Promotion Committee: 100% (2/2)
Member of the Board of Directors (Outside Director)
Minoru Awabayashi
Career summary
| Jul. 1978 | Established Nihon Yo-Flow Co., Ltd. President and Representative Director |
|---|---|
| Jul. 1983 | Established Pacific Marketing Partners, Inc. in the U.S. Managing Director |
| Jul. 1997 | Established Omniglow Japan Co., Ltd. Vice President and Representative Director |
| Apr. 2005 | President and Representative Director, Omniglow Japan Co., Ltd. |
| Apr. 2016 | Senior Vice President, Takenaka Partners Corp. |
| Jun. 2023 | Member of the Board of Directors, Outside Director of the Company (to present) |
| Oct. 2024 | Founder CEO of M&A Strategy Advisors Co., Ltd. (to present) |
-
Important Concurrent Holding of Positions
Founder CEO of M&A Strategy Advisors Co., Ltd. -
Shares held (As of June 24, 2026)
- -
Meeting body attended and attendance status (FY2025)
Board of Directors: 93% (14/15)
Group Nomination Committee: 100% (6/6)
Group Remuneration Committee: 100% (5/5)
Member of the Board of Directors (Outside Director)
Yasuji Enokido
Career summary
| Apr. 1983 | Joined Matsushita Electric Industrial Co. Ltd. (currently Panasonic Corporation) |
|---|---|
| Aug. 2007 | President of Panasonic Avionics Corporation |
| Jun. 2015 | Managing Director of Panasonic Corporation, President of AVC Networks Company |
| Apr. 2016 | Representative Director and Senior Managing Director of Panasonic Corporation |
| Nov. 2017 | Representative Director and President of Soen Co., Ltd. (to present) |
| Sep. 2021 | Outside Director of cars Inc. (to present) |
| Nov. 2021 | Outside Director of Farmnote Holdings, Inc. (to present) |
| Jun. 2023 | Member of the Board of Directors, Outside Director of the Company (to present) |
| Mar. 2024 | Outside Director of Daiwa House Ventures Co., Ltd. (to present) |
| Mar. 2025 | Outside Director of EneCoat Technologies Co., Ltd. (to present) |
-
Important Concurrent Holding of Positions
Representative Director and President of Soen Co., Ltd.
Outside Director of cars Inc.
Outside Director of Farmnote Holdings, Inc.
Outside Director of Daiwa House Ventures Co., Ltd.
Outside Director of EneCoat Technologies Co., Ltd. -
Shares held (As of June 24, 2026)
- -
Meeting body attended and attendance status (FY2025)
Board of Directors: 100% (15/15)
Group Nomination Committee: 100% (6/6)
Group Remuneration Committee: 100% (5/5)
Member of the Board of Directors (Outside Director)
Kanae Karita
Career summary
| Mar. 1986 | Graduated from the School of Health Sciences of the Faculty of Medicine, the University of Tokyo |
|---|---|
| Mar. 1988 | Completed master course of the Graduate School of Medicine, the University of Tokyo |
| Sep. 2007 | Associate Professor of the Department of Hygiene and Public Health, Faculty of Medicine, Kyorin University |
| Apr. 2015 | Professor of the Department of Hygiene and Public Health, Faculty of Medicine, Kyorin University (to present) Director of the Gender Equality Promotion Office, Kyorin University |
| Jun. 2019 | Director of the Japanese Medical Science Federation Director of the Japanese Association of Medical Sciences (to present) |
| Mar. 2022 | Member of the Photochemical Oxidant Health Impact Assessment Committee, Ministry of the Environment |
| Apr. 2024 | Member of the Food Safety Standards Council, Cabinet Office (to present) |
| Jun. 2024 | Member of the Board of Directors, Outside Director of the Company (to present) |
| Jun. 2025 | Auditor of the Japanese Medical Science Federation (to present) |
-
Important Concurrent Holding of Positions
Professor of the Department of Hygiene and Public Health, Faculty of Medicine, Kyorin University
Director of the Japanese Association of Medical Sciences
Member of the Food Safety Standards Council, Cabinet Office
Auditor of the Japanese Medical Science Federation -
Shares held (As of June 24, 2026)
- -
Meeting body attended and attendance status (FY2025)
Board of Directors: 100% (15/15)
Group Nomination Committee: 100% (4/4)
Group Remuneration Committee: 100% (3/3)
Member of the Board of Directors (Outside Director)
Kiyoko Kato
Career summary
| Mar. 1986 | Graduated from the School of Medicine, Kyushu University |
|---|---|
| Jul. 2009 | Associate Professor of the Department of Obstetrics and Gynecology, Juntendo University Graduate School of Medicine |
| Aug. 2012 | Professor, Reproductive Pathological Physiology, Faculty of Medical Sciences, Kyushu University |
| Nov. 2015 | Director, The Japan Society for Menopause and Women’s Health (to present) |
| Jun. 2023 | Chairperson of Japan Society of Obstetrics and Gynecology |
| Jun. 2025 | Member of the Board of Directors, Outside Director of the Company (to present) Executive Director of Japan Society of Obstetrics and Gynecology (to present) Director of the Japanese Medical Science Federation (to present) Director of the Japanese Association of Medical Sciences (to present) |
| Apr. 2026 | Director of Fukuoka Sanno Hospital (to present) Professor, Faculty of Medicine of International University of Health and Welfare Graduate School (to present) |
-
Important Concurrent Holding of Positions
Director, The Japan Society for Menopause and Women’s Health
Executive Director, Japan Society of Obstetrics and Gynecology
Director of the Japanese Medical Science Federation
Director of the Japanese Association of Medical Sciences
Director of Fukuoka Sanno Hospital
Professor, Faculty of Medicine of International University of Health and Welfare Graduate School -
Shares held (As of June 24, 2026)
- -
Meeting body attended and attendance status (FY2025)
Board of Directors: 90% (10/11)
Member of the Board of Directors (Outside Director)
James C. Feliciano
Career summary
| Oct. 2009 | General Manager of Vaccine Business Department, Pfizer Japan Inc. |
|---|---|
| Nov. 2013 | Representative Director and President, Merck Serono Co., Ltd. (currently Merck Biopharma Co., Ltd.) |
| Jun. 2015 | President of AbbVie GK |
| Mar. 2025 | President of 3C Advisor GK (to present) |
| Sep. 2025 | Representative Director and President of Surzen Biotherapeutics Co., Ltd. (to present) |
| Jun. 2026 | Member of the Board of Directors, Outside Director of the Company (to present) |
-
Important Concurrent Holding of Positions
President of 3C Advisor GK
Representative Director and President of Surzen Biotherapeutics Co., Ltd. -
Shares held (As of June 24, 2026)
- -
Meeting body attended and attendance status (FY2025)
Board of Directors: - (Newly appointed)
Member of the Board of Directors, Audit and Supervisory Committee Member
Kunihiro Gunji
Career summary
| Apr. 1984 | Joined ASKA Pharmaceutical Co., Ltd. |
|---|---|
| Oct. 2008 | Director of Sales Planning Promotion Department of ASKA Pharmaceutical Co., Ltd. |
| Oct. 2016 | Assistant Division Director of Sales Division of ASKA Pharmaceutical Co., Ltd. |
| Jun. 2018 | Corporate Officer (Division Director, Development Division) of ASKA Pharmaceutical Co., Ltd. |
| Jun. 2020 | Corporate Officer, in charge of Audit, Legal Affairs & Regulatory Compliance of ASKA Pharmaceutical Co., Ltd. |
| Apr. 2021 | Corporate Officer, in charge of Audit and Legal Affairs & Regulatory Compliance of the Company |
| Oct. 2022 | Corporate Officer (Director, Information service Supervisory Unit) of ASKA Pharmaceutical Co., Ltd. |
| Jun. 2024 | Audit & Supervisory Board Member of the Company (to present) Audit & Supervisory Board Member of ASKA Pharmaceutical Co., Ltd. (to present) Audit & Supervisory Board Member of ASKA Pharma Medical Co., Ltd. (to present) |
| Jun. 2026 | Member of the Board of Directors, Audit and Supervisory Committee Member (to present) |
-
Important Concurrent Holding of Positions
Audit & Supervisory Board Member of ASKA Pharmaceutical Co., Ltd.
Audit & Supervisory Board Member of ASKA Pharma Medical Co., Ltd. -
Shares held (As of June 24, 2026)
12 thousand shares -
Meeting body attended and attendance status (FY2025)
Board of Directors: 100% (15/15)
Audit & Supervisory Board: 100% (17/17)
Member of the Board of Directors, Outside Director, Audit and Supervisory Committee Member
Takao Kimura
Career summary
| Nov. 1975 | Joined Hoechst Japan Ltd. (currently Sanofi K.K.) |
|---|---|
| Jul. 2000 | President and Representative Director of Nycomed Amersham PLC |
| Dec. 2002 | Executive Officer, General Manager of Business Development Division of Aventis Pharma Limited (currently Sanofi K.K.) |
| Apr. 2010 | Executive Officer, Supervising Manager of Business Development Division in Asia-Pacific Region of Sanofi-aventis K.K. (currently Sanofi K.K.) |
| Feb. 2016 | Representative Partner of TK Pharma Partners LLC. |
| Jun. 2017 | Outside Audit & Supervisory Board Member of ASKA Pharmaceutical Co., Ltd. |
| Apr. 2021 | Outside Audit & Supervisory Board Member of the Company |
| Jun. 2026 | Member of the Board of Directors, Outside Director, Audit and Supervisory Committee Member (to present) |
-
Important Concurrent Holding of Positions
- -
Shares held (As of June 24, 2026)
- -
Meeting body attended and attendance status (FY2025)
Board of Directors: 100% (15/15)
Audit & Supervisory Board: 100% (17/17)
Member of the Board of Directors, Outside Director, Audit and Supervisory Committee Member
Koki Yamashita
Career summary
| Apr. 1988 | Joined Tokyo Regional Taxation Bureau |
|---|---|
| Jul. 2014 | Deputy District Director of Kawasaki-nishi Tax Office |
| Jul. 2019 | District Director of Sakyo Tax Office |
| Jul. 2020 | Manager of Co-ordinated Examination and Information Management Division, First Examination Department, Tokyo Regional Taxation Bureau |
| Jul. 2022 | District Director of Kanda Tax Office |
| Aug. 2023 | Tax Accountant LR Partners Kawasaki Office Manager |
| Jun. 2025 | Outside Audit & Supervisory Board Member of the Company |
| Dec. 2025 | Representative of Koki Yamashita Tax Accountant Office (to present) |
| Jun. 2026 | Member of the Board of Directors, Outside Director, Audit and Supervisory Committee Member (to present) |
-
Important Concurrent Holding of Positions
Representative of Koki Yamashita Tax Accountant Office -
Shares held (As of June 24, 2026)
- -
Meeting body attended and attendance status (FY2025)
Board of Directors: 100% (11/11)
Audit & Supervisory Board: 100% (12/12)
Corporate Officers
(As of June 24, 2026)
| Kiyohiko Tamura | Executive Corporate Officer | Division Director, Group Business Management Division, in charge of DX Promotion of the Company Executive Corporate Officer, Division Director, Administrative Division of ASKA Pharmaceutical Co., Ltd. Member of the Board of Directors of ASKA Animal Health Co., Ltd. Member of the Board of Directors of ASKA Pharma Medical Co., Ltd. |
|---|---|---|
| Tomohito Nagao | Corporate Officer | In charge of Audit and Legal Affairs & Regulatory Compliance of the Company Corporate Officer, Director, Information service Supervisory Unit of ASKA Pharmaceutical Co., Ltd. |
| Hidenori Hori | Corporate Officer | President, Member of the Board of Directors, Representative Director of ASKA Pharma Medical Co., Ltd. Director of Femtech Business Promotion Unit of ASKA Pharmaceutical Co., Ltd. |